Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual-Antiplatelet Therapy Strategies for Elective PCI in a Real-World Setting
2021-006072-16Phase 4Terminated
- Sponsor
- Amsterdam University Medical Center
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of clopidogrel in coronary arteriosclerosis (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Net Adverse Clinical Events (NACE). Started Aug 2022; status: terminated.
02
Drugs
clopidogrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2021-006072-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-006072-16.